DelveInsight’s Head and Neck Cancer Market Insights report includes a comprehensive understanding of current treatment practices, head and neck cancer emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM [the United States, the EU5 (the United Kingdom, Italy, Spain, France, and Germany), Japan].
Key Takeaways from the Head and Neck Cancer Market Report
Discover which therapies are expected to grab the major head and neck cancer market share @ Head and Neck Cancer Market Report
Head and Neck Cancer Overview
Head and neck cancer (HNC) usually begins in the squamous cells – also known as squamous cell carcinomas of the head and neck – that line the mucosal surfaces of the head and neck (for example, those inside the mouth, throat, and voice box), but it can also begin in the salivary glands, sinuses, muscles, or nerves. Alcohol and tobacco use are the two most important risk factors for head and neck causes.
Head and neck cancer symptoms include a lump in the neck or a sore in the mouth or throat that does not heal, a persistent sore throat, difficulty swallowing, and a change or hoarseness in the voice; however, these head and neck cancer symptoms can also be caused by other, less serious illnesses.
Physical examination/blood and urine tests, endoscopy, biopsy, biomarker testing of the tumor, X-ray/barium swallow, panoramic radiograph, ultrasound, magnetic resonance imaging, bone scan, and other tests are used for head and neck diagnosis.
Head and Neck Cancer Epidemiology Segmentation
The head and neck cancer market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:
Download the report to understand which factors are driving head and neck cancer epidemiology trends @ Head and Neck Cancer Epidemiological Insights
Head and Neck Cancer Treatment Market
Chemotherapy has widely used in all lines of head and neck treatment among all available therapeutic options. Numerous drugs have been identified with the advancement of medical technologies and increased research and development activities. Immunotherapeutic options for treating HNC patients have also been identified.
Overall, head and neck cancer treatment options for patients with HNC include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy. Pharmacological therapies are primarily used to destroy cancer cells and are administered systematically or locally (by a medical oncologist). Chemotherapy, targeted therapy, and immunotherapy are some of the pharmacological head and neck cancer treatments available to HNC patients.
Across all countries, the most common first-line systemic therapy regimens were platinum-based combinations, such as platinum + 5-F, cetuximab + platinum 5-FU, or taxane + platinum 5-FU. However, the use of different platinum-based combinations varied significantly across countries; administration of cetuximab + platinum 5-FU was common in Italy, Germany, and Spain. In the United Kingdom, platinum with 5-FU was the most commonly used first-line regimen.
Head and Neck Cancer Pipeline Therapies and Key Companies
Report Metrics
Details
Study Period
2019–2032
Coverage
7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
Base Year
2021
Market CAGR
5.1 %
Market Size in 2021
USD 2.9 Billion
Key Head and Neck Cancer Companies
CEL-SCI, Junshi Biosciences, Coherus, Exelixis, Immutep S.A.S., Merck Sharp & Dohme LLC, Iovance Biotherapeutics, BeiGene, Akeso, Chia Tai-Tianqing, Kura Oncology, Hoffmann-La Roche, Eli Lilly and Company, and others
Key Head and Neck Cancer Therapies
Leukocyte Interleukin (MULTIKINE), Toripalimab, Cabozantinib, Eftilagimod alpha (Efti/IMP321), LN-145 (Tumor Infiltrating Lymphocytes), Tislelizumab, Penpulimab/AK105, Tipifarnib, XEVINAPANT (Debio 1143), TECENTRIQ (atezolizumab), Cyramza (ramucirumab), and others
Scope of the Head and Neck Cancer Market Report
Discover more about drugs for head and neck cancer in development @ Head and Neck Cancer Clinical Trials
Table of Contents
1.
Head and Neck Cancer Market Key Insights
2.
Head and Neck Cancer Market Report Introduction
3.
Head and Neck Cancer Market Overview at a Glance
4.
Head and Neck Cancer Market Executive Summary
5.
Disease Background and Overview
6.
Head and Neck Cancer Treatment and Management
7.
Head and Neck Cancer Epidemiology and Patient Population
8.
Patient Journey
9.
Head and Neck Cancer Emerging Drugs
10.
Seven Major Head and Neck Cancer Market Analysis
11.
Head and Neck Cancer Market Outlook
12.
Potential of Current and Emerging Therapies
13.
KOL Views
14.
Head and Neck Cancer Market Drivers
15.
Head and Neck Cancer Market Barriers
16.
Unmet Needs
17.
SWOT Analysis
18.
Appendix
19.
DelveInsight Capabilities
20.
Disclaimer
21.
About DelveInsight
To know more about head and neck cancer treatment options, visit @ New Treatment for Head and Neck Cancer
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Gaurav BoraEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/